N. Maouche

Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort

K. Ramasamy, S. Basu, J. Kothari, 2022, PloS one.

Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

M. Dimopoulos, R. Hájek, M. Jenner, 2020, Annals of Hematology.

Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.

S. Misbah, K. Jeffery, V. Rocha, 2019, The Journal of infection.

Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience

M. Jenner, K. Ramasamy, K. Boyd, 2020, Leukemia & lymphoma.

"Real World" Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Combined Study from the Greek, Czech and UK Databases

M. Dimopoulos, R. Hájek, M. Jenner, 2017 .

Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort

K. Ramasamy, J. Kothari, A. Srinivasan, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.